Patent 9169491 was granted and assigned to Oxford Biomedica (UK) Limited on October, 2015 by the United States Patent and Trademark Office.
A process for producing a retroviral or lentiviral vector formulation comprising a filter-sterilization step wherein the filter-sterilization step is not the final step in the purification process.